Rivaroxaban is a direct inhibitor of coagulation factor Xa and is used for venous thromboembolic disorders. The rivaroxaban interaction with BSA was studied to understand its PK and PD (pharmacokinetics and pharmacokinetics) properties. | Study of binding interaction of rivaroxaban with bovine serum albumin using multi-spectroscopic and molecular docking approach